IDF23-0223 Targeting miR-122 and miR-4756 mitigates atherogenic events by upregulating Sestrin2 under high glucose condition

Autor: Rajagopal, A., Venkatesan, S., Balasubramanyam, M., Anjana, R.M., Mohan, V., Manickam, N.
Zdroj: In Diabetes Research and Clinical Practice March 2024 209 Supplement 1
Databáze: ScienceDirect